Infusion Therapy Market

Infusion Therapy Market (Product: Infusion Pumps, Infusion Set, and Accessories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Infusion Therapy Market Outlook 2031

  • The industry was valued at US$ 41.7 Bn in 2021
  • It is projected to grow at a CAGR of 6.7% from 2022 to 2031 and reach more than US$ 78.9 Mn by the end of 2031

Analysts’ Viewpoint

Infusion therapy involves usage of sterilized needles and catheters to administer a drug via non-oral routes such as intramuscular injections and epidural routes. Rise in prevalence of chronic diseases, such as cancer, neurological diseases, and gastrointestinal diseases, is expected to drive the global market from 2021 to 2031. Increase in elderly population, changing infusion therapy demand environment, and severe orthopedic diseases are boosting the global infusion therapy market share.

Development of advanced, cost-effective, and user-friendly home infusion kits presents significant opportunities for manufacturers in the business in the next few years. Key players are focusing on strategies such as merger & acquisition, new product launches, and technological innovations to increase their market footprint.

Infusion Therapy Market

Global Infusion Therapy Market Overview

Infusion therapy is used to treat medical conditions, such as infections and diseases, that do not respond to oral antibiotics. An infusion therapy provider is someone who specializes in administering infusion therapies to patients in their homes or other alternative settings. This is referred to as a home infusion therapy pharmacy. Comprehensive service, prescription drugs, and biologics can be safely and effectively administered in patients' homes or other locations.

Rise in hospital-acquired infections (HAIs), which are caused by contact with contaminated tools, bedclothes, and air droplets throughout facilities, is fueling market development. Furthermore, demand for home infusion therapy is rising to reduce the likelihood of infection and ensure the best possible care. Development of low-cost, user-friendly home infusion kits is another factor propelling the industry.

Rise in Prevalence of Cancer Propelling Infusion Therapy Market Demand

Cancer is the second leading cause of death globally. It occurs due to development of abnormal cells, which further divide uncontrollably. These abnormal cells further form a mass like structure, which is called tumor. According to the WHO, cancer accounted for nearly 10 million deaths globally in 2020, which is one in six deaths. The most common cancers are breast, prostrate, lung colon, and rectum.

Diabetes is another chronic disease, which leads to large number of deaths. According to the Centers for Disease Control and Prevention, around 37 million people die in the U.S. due to diabetes.

Cardiovascular diseases are the leading causes of death globally. Heart attacks and strokes are the most common acute events. These are primarily caused due to blockages in the blood vessels, which prevent the blood from flowing to the brain or heart. The reasons for heart failure could include unhealthy diet and addictions such as tobacco and smoking. According to the WHO, in 2019, CVDs accounted for an estimated 17.9 million deaths; of these 85% were due to heart attack and stroke, and more than 75% deaths occur in the low & middle income countries.

Thus, rise in the number of infusion therapies due to the increase in incidence of these chronic diseases is driving the infusion therapy market size.

Reduction of Human Errors Due to Advanced Infusion Pumps

Infusion pumps are used in various applications in the medical field. In some cases, there are chances of getting an incorrect infusion into a patient’s body, which could hamper a patient's health. However, advanced pumps are available that directly deliver fluids or medications more efficiently into the patient’s blood stream. This minimizes human errors. Advanced pumps, such as ‘Sigma Spectrum’ and other smart pumps, contain drug libraries with a digital regulation within the pump itself to minimize the errors.

The two basic classes of infusion pumps are large volume pumps and small volume pumps. Large volume pumps are used to deliver nutrients, while small pumps are utilized to deliver medications and hormones. In the case of chemotherapy infusion, the medicines (of around 100 agents) used to treat cancer are introduced through a pump that controls the rate and amount of infusion. Generally, chemotherapy medications are infused through a vein in the patient’s hand or arm. However, these are sometimes infused through a specific port or are injected under the skin. These medications further circulate in the body and fight against the disease.

Therefore, usage of advanced infusion pumps, such as IP-200 infusion system, that can minimize errors is likely to propel market expansion.

Increase in Demand for Portable Infusion Therapy Pumps

In terms of product, the accessories segment dominated the global industry in 2021. The trend is expected to continue during the forecast period. According to a featured article by Wolters Kluwer Health, Inc., over 90% of hospitalized patients in the U.S. received IV medications, with the majority of them delivered via portable infusion pump.

Rise in Prevalence of Cancer Fueling Market Progress

Based on indication, the cancer segment led the global infusion therapy market in 2021. Just as the prevalence of target illnesses such as cancer, viral infections, and tuberculosis (TB) has increased, so has the usage of IV infusion pump accessories.

Infusion products are used to administer analgesics, anesthetics, antipyretics, antibiotics, anticancer medications, and other medications. Usage of medications to treat or eliminate cancer cells is one of the most commonly adopted cancer treatments. Chemotherapy fights cancer cells in various ways, including interfering with the ability of cancer cells to grow or reproduce. Cancer is also commonly treated with more than one medicine at the same time. Chemotherapy could be used alone or in combination with other treatments such as radiation or surgery.

High Demand for Antibiotic/Antiviral Intravenous (IV) Infusion Therapy

In terms of therapy, the antibiotic/antiviral segment dominated the global market in 2021. The trend is expected to continue during the forecast period. Antibiotic intravenous (IV) infusion therapy is a common therapy in hospitals. It has gained popularity in the past few years, coinciding with the rise in bacterial resistance to several commonly used oral antibiotics. In these cases, antibiotic IV infusion therapy is the last line of defense against these types of bacteria, which are already one of the most serious threats to human health in the 21st century.

Surge in Coronavirus Cases Due to New Strains

Based on end-user, the hospitals segment dominated the global market in 2021. The trend is expected to continue during the forecast period. New coronavirus strains have been reported in several parts of the world, resulting in rise in cases. This has increased the number of hospital admissions.

Many patients are being placed on ventilators for critical care, particularly the elderly and those with severe lung infections. Intravenous solutions are constantly administered to such patients in order to maintain adequate nutrition.

Regional Analysis of Global Infusion Therapy Market

According to the infusion therapy industry report, North America held the largest share in 2021, led by the increase in medications used to treat chronic and uncommon diseases through infusion therapy. Rise in prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes; increase in geriatric population; and rapid technological advancements in the healthcare sector contribute to the region's global dominance.

Investment in the healthcare market in North America has increased in the past few years. Improved quality of life due to economic development has propelled market expansion in the region.

The market in Asia Pacific is expected to grow at a rapid pace during the forecast period owing to rapid adoption of new technologies in the infusion therapy industry and rise in prevalence of chronic diseases.

Analysis of Key Players

Leading companies in the global market are Becton, Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, ICU Medical, Inc., Fresenius SE & Co. KGaA, Medtronic, Inc., Terumo Corporation, CareFusion Corporation, and Polymedicure. These companies are focusing on strategic acquisitions and partnerships to expand their product portfolio.

Key Developments in Global Infusion Therapy Market

  • In February 2022, B. Braun, one of the leading companies in the medical technology and a provider of infusion therapy & pain management solutions, received the FDA approval for Daytona Beach Pharmaceutical Manufacturing Site. The new Daytona Beach facility is part of the company's commitment to invest more than US$ 1 Bn in the U.S. to alleviate IV fluid shortages by increasing supply and manufacturing capacity. B. Braun now has strategic manufacturing locations on both coasts, thanks to its existing IV solutions plant in Irvine, California.

Prominent players have been profiled in the infusion therapy market report based on parameters such as product portfolio, recent developments, financial overview, company overview, strategies, and segments.

Global Infusion Therapy Market Snapshot

Attribute

Detail

Size in 2021

US$ 41.7 Bn

Forecast (Value) in 2031

More than US$ 78.9 Bn

Compound Annual Growth Rate (CAGR)

6.7%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Product
    • Infusion Pumps
      • Ambulatory Infusion Pumps
      • Stationary Infusion Pumps
      • Syringe Infusion Pumps
      • Disposable Pumps
      • Large Volume Pumps
      • Elastomeric pumps
    • Infusion Set
    • Accessories
  • Indication
    • Cancer
    • Gastrointestinal Diseases/Disorders
    • Congestive Heart Failure
    • Rheumatoid Arthritis
    • Hemophilia
    • Immune Deficiencies
    • Others
  • Therapy
    • Antibiotic/Antiviral
    • Anti-coagulation
    • Anti-emetics
    • Blood Component Stimulating Factor
    • Chemotherapy
    • Nutrition
    • Hydration
    • Pain Management
  • End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Clinics
    • Homecare Settings

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • B. Braun Melsungen AG
  • Medtronic plc
  • Becton, Dickinson and Company
  • ICU medical (Smiths Medical)
  • Baxter International, Inc.
  • Polymedicure
  • BIO-MED
  • Terumo Medical Corporation
  • MEDIPRIM GmbH
  • Fresenius Kabi
  • Cardinal Health

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global infusion therapy market in 2021?

The global industry was valued at US$ 41.7 Bn in 2021

How big will it be in 2031?

It is projected to reach more than US$ 78.9 Bn by 2031

What was the CAGR from 2017 to 2021)?

The CAGR was 4.7% from 2017 to 2021

What will be the CAGR during the forecast period?

The CAGR is anticipated to be 6.7% from 2022 to 2031

What are the prominent trends that affect growth?

Rise in prevalence of chronic diseases such as cardiovascular & cancer and reduction of human errors due to advanced infusion pumps

What is the share of leading segment?

The accessories segment held more than 35.0% share in 2021

Which region is likely to account for major share?

North America is expected to account for significant share during the forecast period.

Who are the prominent players in the business?

Becton, Dickinson and Company, Baxter International, Inc., B. Braun Melsungen AG, ICU Medical, Inc., Fresenius SE & Co. KGaA, Medtronic, plc, Terumo Corporation, CareFusion Corporation, and Polymedicure

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Infusion Therapy Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Porter’s Five Force Analysis

    5. Key Insights

        5.1. Key Industry Developments

        5.2. Disease Prevalence & Incidence Rate globally with key countries

        5.3. Technological Advancements

        5.4. Regulatory Scenario by Region/globally

        5.5. Covid-19 Pandemic impact on the industry

    6. Global Infusion Therapy Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product, 2017–2031

            6.3.1. Infusion Pumps

                6.3.1.1. Ambulatory Infusion Pumps

                6.3.1.2. Stationary Infusion Pumps

                6.3.1.3. Syringe Infusion Pumps

                6.3.1.4. Disposable Pumps

                6.3.1.5. Large Volume Pumps

                6.3.1.6. Elastomeric Pumps

            6.3.2. Infusion Set

            6.3.3. Accessories

        6.4. Market Attractiveness Analysis, by Product

    7. Global Infusion Therapy Market Analysis and Forecast, by Indication

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Indication, 2017–2031

            7.3.1. Cancer

            7.3.2. Gastrointestinal Diseases / Disorders

            7.3.3. Congestive Heart Failure

            7.3.4. Rheumatoid Arthritis

            7.3.5. Hemophilia

            7.3.6. Immune Deficiencies

            7.3.7. Others

        7.4. Market Attractiveness Analysis, by Indication

    8. Global Infusion Therapy Market Analysis and Forecast, by Therapy Type

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Therapy Type, 2017–2031

            8.3.1. Antibiotic/Antiviral

            8.3.2. Anti-coagulation

            8.3.3. Anti-emetics

            8.3.4. Blood Component Stimulating Factor

            8.3.5. Chemotherapy

            8.3.6. Nutrition

            8.3.7. Hydration

            8.3.8. Pain Management

        8.4. Market Attractiveness Analysis, by Therapy Type

    9. Global Infusion Therapy Market Analysis and Forecast, by End-user

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Market Value Forecast, by End-user, 2017–2031

            9.3.1. Hospitals

            9.3.2. Ambulatory Surgical Centers

            9.3.3. Clinics

            9.3.4. Homecare Settings

        9.4. Market Attractiveness Analysis, by End-user

    10. Global Infusion Therapy Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness Analysis, by Region

    11. North America Infusion Therapy Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2017–2031

            11.2.1. Infusion Pumps

                11.2.1.1. Ambulatory Infusion Pumps

                11.2.1.2. Stationary Infusion Pumps

                11.2.1.3. Syringe Infusion Pumps

                11.2.1.4. Disposable Pumps

                11.2.1.5. Large Volume Pumps

                11.2.1.6. Elastomeric Pumps

            11.2.2. Infusion Set

            11.2.3. Accessories

        11.3. Market Value Forecast, by Indication, 2017–2031

            11.3.1. Cancer

            11.3.2. Gastrointestinal Diseases / Disorders

            11.3.3. Congestive Heart Failure

            11.3.4. Rheumatoid Arthritis

            11.3.5. Hemophilia

            11.3.6. Immune Deficiencies

            11.3.7. Others

        11.4. Market Value Forecast, by Therapy Type, 2017–2031

            11.4.1. Antibiotic/Antiviral

            11.4.2. Anti-coagulation

            11.4.3. Anti-emetics

            11.4.4. Blood Component Stimulating Factor

            11.4.5. Chemotherapy

            11.4.6. Nutrition

            11.4.7. Hydration

            11.4.8. Pain Management

        11.5. Market Value Forecast, by End-user, 2017–2031

            11.5.1. Hospitals

            11.5.2. Ambulatory Surgical Centers

            11.5.3. Clinics

            11.5.4. Homecare Settings

        11.6. Market Value Forecast, by Country, 2017–2031

            11.6.1. U.S.

            11.6.2. Canada

        11.7. Market Attractiveness Analysis

            11.7.1. By Product

            11.7.2. By Indication

            11.7.3. By Therapy Type

            11.7.4. By End-user

            11.7.5. By Country

    12. Europe Infusion Therapy Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2017–2031

            12.2.1. Infusion Pumps

                12.2.1.1. Ambulatory Infusion Pumps

                12.2.1.2. Stationary Infusion Pumps

                12.2.1.3. Syringe Infusion Pumps

                12.2.1.4. Disposable Pumps

                12.2.1.5. Large Volume Pumps

                12.2.1.6. Elastomeric Pumps

            12.2.2. Infusion Set

            12.2.3. Accessories

        12.3. Market Value Forecast, by Indication, 2017–2031

            12.3.1. Cancer

            12.3.2. Gastrointestinal Diseases / Disorders

            12.3.3. Congestive Heart Failure

            12.3.4. Rheumatoid Arthritis

            12.3.5. Hemophilia

            12.3.6. Immune Deficiencies

            12.3.7. Others

        12.4. Market Value Forecast, by Therapy Type, 2017–2031

            12.4.1. Antibiotic/Antiviral

            12.4.2. Anti-coagulation

            12.4.3. Anti-emetics

            12.4.4. Blood Component Stimulating Factor

            12.4.5. Chemotherapy

            12.4.6. Nutrition

            12.4.7. Hydration

            12.4.8. Pain Management

        12.5. Market Value Forecast, by End-user, 2017–2031

            12.5.1. Hospitals

            12.5.2. Ambulatory Surgical Centers

            12.5.3. Clinics

            12.5.4. Homecare Settings

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Italy

            12.6.5. Spain

            12.6.6. Rest of Europe

        12.7. Market Attractiveness Analysis

            12.7.1. By Product

            12.7.2. By Indication

            12.7.3. By Therapy Type

            12.7.4. By End-user

            12.7.5. By Country/Sub-region

    13. Asia Pacific Infusion Therapy Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2017–2031

            13.2.1. Infusion Pumps

                13.2.1.1. Ambulatory Infusion Pumps

                13.2.1.2. Stationary Infusion Pumps

                13.2.1.3. Syringe Infusion Pumps

                13.2.1.4. Disposable Pumps

                13.2.1.5. Large Volume Pumps

                13.2.1.6. Elastomeric Pumps

            13.2.2. Infusion Set

            13.2.3. Accessories

        13.3. Market Value Forecast, by Indication, 2017–2031

            13.3.1. Cancer

            13.3.2. Gastrointestinal Diseases / Disorders

            13.3.3. Congestive Heart Failure

            13.3.4. Rheumatoid Arthritis

            13.3.5. Hemophilia

            13.3.6. Immune Deficiencies

            13.3.7. Others

        13.4. Market Value Forecast, by Therapy Type, 2017–2031

            13.4.1. Antibiotic/Antiviral

            13.4.2. Anti-coagulation

            13.4.3. Anti-emetics

            13.4.4. Blood Component Stimulating Factor

            13.4.5. Chemotherapy

            13.4.6. Nutrition

            13.4.7. Hydration

            13.4.8. Pain Management

        13.5. Market Value Forecast, by End-user, 2017–2031

            13.5.1. Hospitals

            13.5.2. Ambulatory Surgical Centers

            13.5.3. Clinics

            13.5.4. Homecare Settings

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. China

            13.6.2. Japan

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Market Attractiveness Analysis

            13.7.1. By Product

            13.7.2. By Indication

            13.7.3. By Therapy Type

            13.7.4. By End-user

            13.7.5. By Country/Sub-region

    14. Latin America Infusion Therapy Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product, 2017–2031

            14.2.1. Infusion Pumps

                14.2.1.1. Ambulatory Infusion Pumps

                14.2.1.2. Stationary Infusion Pumps

                14.2.1.3. Syringe Infusion Pumps

                14.2.1.4. Disposable Pumps

                14.2.1.5. Large Volume Pumps

                14.2.1.6. Elastomeric Pumps

            14.2.2. Infusion Set

            14.2.3. Accessories

        14.3. Market Value Forecast, by Indication, 2017–2031

            14.3.1. Cancer

            14.3.2. Gastrointestinal Diseases / Disorders

            14.3.3. Congestive Heart Failure

            14.3.4. Rheumatoid Arthritis

            14.3.5. Hemophilia

            14.3.6. Immune Deficiencies

            14.3.7. Others

        14.4. Market Value Forecast, by Therapy Type, 2017–2031

            14.4.1. Antibiotic/Antiviral

            14.4.2. Anti-coagulation

            14.4.3. Anti-emetics

            14.4.4. Blood Component Stimulating Factor

            14.4.5. Chemotherapy

            14.4.6. Nutrition

            14.4.7. Hydration

            14.4.8. Pain Management

        14.5. Market Value Forecast, by End-user, 2017–2031

            14.5.1. Hospitals

            14.5.2. Ambulatory Surgical Centers

            14.5.3. Clinics

            14.5.4. Homecare Settings

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of Latin America

        14.7. Market Attractiveness Analysis

            14.7.1. By Product

            14.7.2. By Indication

            14.7.3. By Therapy Type

            14.7.4. By End-user

            14.7.5. By Country/Sub-region

    15. Middle East & Africa Infusion Therapy Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Product, 2017–2031

            15.2.1. Infusion Pumps

                15.2.1.1. Ambulatory Infusion Pumps

                15.2.1.2. Stationary Infusion Pumps

                15.2.1.3. Syringe Infusion Pumps

                15.2.1.4. Disposable Pumps

                15.2.1.5. Large Volume Pumps

                15.2.1.6. Elastomeric Pumps

            15.2.2. Infusion Set

            15.2.3. Accessories

        15.3. Market Value Forecast, by Indication, 2017–2031

            15.3.1. Cancer

            15.3.2. Gastrointestinal Diseases / Disorders

            15.3.3. Congestive Heart Failure

            15.3.4. Rheumatoid Arthritis

            15.3.5. Hemophilia

            15.3.6. Immune Deficiencies

            15.3.7. Others

        15.4. Market Value Forecast, by Therapy Type, 2017–2031

            15.4.1. Antibiotic/Antiviral

            15.4.2. Anti-coagulation

            15.4.3. Anti-emetics

            15.4.4. Blood Component Stimulating Factor

            15.4.5. Chemotherapy

            15.4.6. Nutrition

            15.4.7. Hydration

            15.4.8. Pain Management

        15.5. Market Value Forecast, by End-user, 2017–2031

            15.5.1. Hospitals

            15.5.2. Ambulatory Surgical Centers

            15.5.3. Clinics

            15.5.4. Homecare Settings

        15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of Middle East & Africa

        15.7. Market Attractiveness Analysis

            15.7.1. By Product

            15.7.2. By Indication

            15.7.3. By Therapy Type

            15.7.4. By End-user

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player - Competition Matrix (by tier and size of companies)

        16.2. Market Share Analysis, by Company, 2021

        16.3. Company Profiles

            16.3.1. B. Braun Melsungen AG

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Product Portfolio

                16.3.1.3. Financial Overview

                16.3.1.4. SWOT Analysis

                16.3.1.5. Strategic Overview

            16.3.2. Medtronic plc

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Product Portfolio

                16.3.2.3. Financial Overview

                16.3.2.4. SWOT Analysis

                16.3.2.5. Strategic Overview

            16.3.3. Becton, Dickinson and Company

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Product Portfolio

                16.3.3.3. Financial Overview

                16.3.3.4. SWOT Analysis

                16.3.3.5. Strategic Overview

            16.3.4. ICU medical (Smiths Medical)

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Product Portfolio

                16.3.4.3. Financial Overview

                16.3.4.4. SWOT Analysis

                16.3.4.5. Strategic Overview

            16.3.5. Baxter International, Inc.

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Product Portfolio

                16.3.5.3. Financial Overview

                16.3.5.4. SWOT Analysis

                16.3.5.5. Strategic Overview

            16.3.6. Polymedicure

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Product Portfolio

                16.3.6.3. Financial Overview

                16.3.6.4. SWOT Analysis

                16.3.6.5. Strategic Overview

            16.3.7. BIO-MED

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Product Portfolio

                16.3.7.3. Financial Overview

                16.3.7.4. SWOT Analysis

                16.3.7.5. Strategic Overview

            16.3.8. Terumo Medical Corporation

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Product Portfolio

                16.3.8.3. Financial Overview

                16.3.8.4. SWOT Analysis

                16.3.8.5. Strategic Overview

            16.3.9. MEDIPRIM GmbH

                16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.9.2. Product Portfolio

                16.3.9.3. Financial Overview

                16.3.9.4. SWOT Analysis

                16.3.9.5. Strategic Overview

            16.3.10. Fresenius Kabi

                16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.10.2. Product Portfolio

                16.3.10.3. Financial Overview

                16.3.10.4. SWOT Analysis

                16.3.10.5. Strategic Overview

            16.3.11. Cardinal Health

                16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.11.2. Product Portfolio

                16.3.11.3. Financial Overview

                16.3.11.4. SWOT Analysis

                16.3.11.5. Strategic Overview

    List of Tables

    Table 01: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031

    Table 02: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031

    Table 03: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031

    Table 04: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

    Table 05: Global Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031

    Table 06: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Region, 2017–2031 

    Table 07: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Country, 2017–2031

    Table 08: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031

    Table 09: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031

    Table 10: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031

    Table 11: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

    Table 12: North America Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031

    Table 13: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031

    Table 15: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031

    Table 16: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031

    Table 17: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

    Table 18: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031

    Table 19: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

    Table 20: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031

    Table 21: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031

    Table 22: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031

    Table 23: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

    Table 24: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031

    Table 25: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

    Table 26: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031

    Table 27: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031

    Table 28: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031

    Table 29: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

    Table 30: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031

    Table 31: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031

    Table 32: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031

    Table 33: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031

    Table 34: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031

    Table 35: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031

    Table 36: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Infusion Therapy Market Value Share, by Product, 2021 and 2031

    Figure 02: Global Infusion Therapy Market Attractiveness Analysis, Product, 2022–2031

    Figure 03: Global Infusion Therapy Market (US$ Bn), by Infusion Pumps, 2017–2031

    Figure 04: Global Infusion Therapy Market (US$ Bn), by Infusion Set, 2017–2031

    Figure 05: Global Infusion Therapy Market (US$ Bn), by Accessories, 2017–2031

    Figure 06: Global Infusion Therapy Market, by Indication, 2021 and 2031

    Figure 07: Global Infusion Therapy Market Attractiveness Analysis, Indication, 2022–2031

    Figure 08: Global Infusion Therapy Market (US$ Bn), by Cancer, 2017–2031

    Figure 09: Global Infusion Therapy Market (US$ Bn), by Gastrointestinal Diseases/Disorders, 2017–2031

    Figure 10: Global Infusion Therapy Market (US$ Bn), by Congestive Heart Failure, 2017–2031

    Figure 11: Global Infusion Therapy Market (US$ Bn), by Rheumatoid Arthritis, 2017–2031

    Figure 12: Global Infusion Therapy Market (US$ Bn), by Hemophilia, 2017–2031

    Figure 13: Global Infusion Therapy Market (US$ Bn), by Immune Deficiencies, 2017–2031

    Figure 14: Global Infusion Therapy Market (US$ Bn), by Others, 2017–2031

    Figure 15: Global Infusion Therapy Market, by Therapy, 2021 and 2031

    Figure 16: Global Infusion Therapy Market Attractiveness Analysis, Therapy, 2022–2031

    Figure 17: Global Infusion Therapy Market (US$ Bn), by Antibiotic/Antiviral, 2017–2031

    Figure 18: Global Infusion Therapy Market (US$ Bn), by Anti-coagulation, 2017–2031

    Figure 19: Global Infusion Therapy Market (US$ Bn), by Anti-emetics, 2017–2031

    Figure 20: Global Infusion Therapy Market (US$ Bn), by Blood Component Stimulating Factor, 2017–2031

    Figure 21: Global Infusion Therapy Market (US$ Bn), by Chemotherapy, 2017–2031

    Figure 22: Global Infusion Therapy Market (US$ Bn), by Nutrition, 2017–2031

    Figure 23: Global Infusion Therapy Market (US$ Bn), by Hydration, 2017–2031

    Figure 24: Global Infusion Therapy Market (US$ Bn), by Pain Management, 2017–2031

    Figure 25: Global Infusion Therapy Market, by End-user, 2021 and 2031

    Figure 26: Global Infusion Therapy Market Attractiveness Analysis, End-user, 2022–2031

    Figure 27: Global Infusion Therapy Market (US$ Bn), by Hospitals, 2017–2031

    Figure 28: Global Infusion Therapy Market (US$ Bn), by Ambulatory Surgical Centers, 2017–2031

    Figure 29: Global Infusion Therapy Market (US$ Bn), by Clinics, 2017–2031

    Figure 30: Global Infusion Therapy Market (US$ Bn), by Homecare Settings, 2017–2031

    Figure 31: Global Infusion Therapy Market Value Share Analysis, by Region, 2021 and 2031

    Figure 32: Global Infusion Therapy Market Attractiveness Analysis, by Region, 2022–2031

    Figure 33: North America Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 34: North America Infusion Therapy Market Value Share Analysis, by Country, 2021 and 2031

    Figure 35: North America Infusion Therapy Market Attractiveness Analysis, by Country, 2022–2031

    Figure 36: North America Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031

    Figure 37: North America Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031

    Figure 38: North America Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031

    Figure 39: North America Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031

    Figure 40: North America Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

    Figure 41: North America Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

    Figure 42: North America Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 43: North America Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 44: Europe Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 45: Europe Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 46: Europe Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 47: Europe Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031

    Figure 48: Europe Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031

    Figure 49: Europe Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031

    Figure 50: Europe Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031

    Figure 51: Europe Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

    Figure 52: Europe Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

    Figure 53: Europe Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 54: Europe Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 55: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 56: Asia Pacific Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 57: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 58: Asia Pacific Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031

    Figure 59: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031

    Figure 60: Asia Pacific Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031

    Figure 61: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031

    Figure 62: Asia Pacific Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

    Figure 63: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

    Figure 64: Asia Pacific Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 65: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 66: Latin America Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 67: Latin America Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 68: Latin America Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 69: Latin America Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031

    Figure 70: Latin America Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031

    Figure 71: Latin America Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031

    Figure 72: Latin America Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031

    Figure 73: Latin America Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

    Figure 74: Latin America Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

    Figure 75: Latin America Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 76: Latin America Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 77: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 78: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 79: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 80: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031

    Figure 81: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031

    Figure 82: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031

    Figure 83: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031

    Figure 84: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031

    Figure 85: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031

    Figure 86: Middle East & Africa Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 87: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031

Copyright © Transparency Market Research, Inc. All Rights reserved